These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10627559)

  • 1. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.
    Zhou L; Luo Y; Wu Y; Tsao J; Luo M
    J Virol; 2000 Feb; 74(3):1477-85. PubMed ID: 10627559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
    Upfold N; Ross C; Bishop ÖT; Luke GA; Knox C
    Virus Res; 2018 Jan; 244():153-163. PubMed ID: 29155139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
    Jnaoui K; Minet M; Michiels T
    J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection.
    Kumar AS; Kallio P; Luo M; Lipton HL
    J Virol; 2003 Feb; 77(4):2709-16. PubMed ID: 12552011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system.
    Lipton HL; Kumar AS; Hertzler S; Reddi HV
    Glycoconj J; 2006 Feb; 23(1-2):39-49. PubMed ID: 16575521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
    Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
    Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.
    Kumar AS; Reddi HV; Kung AY; Dal Canto M; Lipton HL
    J Virol; 2004 Aug; 78(16):8860-7. PubMed ID: 15280494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment.
    Shah AH; Lipton HL
    Virology; 2002 Dec; 304(2):443-50. PubMed ID: 12504583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.
    Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2009 Jan; 15(1):81-9. PubMed ID: 19115131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.
    Tsunoda I; Wada Y; Libbey JE; Cannon TS; Whitby FG; Fujinami RS
    J Virol; 2001 Aug; 75(16):7494-505. PubMed ID: 11462022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus.
    McCright IJ; Tsunoda I; Libbey JE; Fujinami RS
    J Neurovirol; 2002 Apr; 8(2):100-10. PubMed ID: 11935462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Theiler's virus with altered tropism for the central nervous system.
    Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
    J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.
    Libbey JE; McCright IJ; Tsunoda I; Wada Y; Fujinami RS
    J Neurovirol; 2001 Apr; 7(2):97-104. PubMed ID: 11517382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactose is needed only for expression of co-receptors used by Theiler's murine encephalomyelitis virus as the virus does not directly bind galactose or use the UDP-galactose transporter as a receptor.
    Reddi HV; Kallio P; Lipton HL
    J Gen Virol; 2003 Apr; 84(Pt 4):845-849. PubMed ID: 12655085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.